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PhototoxicityAbstract The antihistaminic drug trimeprazine (1, also known as alimemazine) is photolabile
under UV-A light in aerobic conditions. Irradiation of a methanol solution of trimeprazine pro-
duces two photoproducts which were isolated as N,N2-trimethyl-3-(10H-phenothiazin-10-yl sulfox-
ide) propan-1-amine (2) and N,2-dimethyl-3-(10H-phenothiazin-10-yl) propan-1-amine (4). The
formation of products was explained by the oxidative photodegradation of trimeprazine in an irre-
versible trapping of the self-photogenerated 1O2 by the type II photodynamic action of the drug.
The generation of singlet oxygen during photolysis of trimeprazine was conﬁrmed by singlet oxygen
scavenger 2,5-dimethylfuran (2,5-DMF).
ª 2012 Production and hosting by Elsevier B.V. on behalf of King Saud University. This is an open access
article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Recently, much attention has turned to the problem of biolog-
ical photosensitization by drugs. Indeed, despite their excellent
therapeutic activity, many drugs can induce phototoxic, pho-
toallergic and photomutagenic phenomena, strictly related to
the drug’s photochemical reactivity (Sortino et al., 2003) Photo-
sensitization reactions leading to phototoxicity are generally
considered as belonging to either the type I (radical mediated)
or type II (singlet oxygen mediated) (Cosa, 2004; Ouedraogo
and Redmond, 2003). There are photosensitizing drugs of
varied structural variety and signiﬁcant variations in the photo-toxic mechanisms must be expected depending on the difference
in structural features. The variety and number of phototoxic
drugs is large and a relationship between structure and the
mechanism of chemical reaction that causes the in vivo photo-
toxicity is not available (Vargas and Rivas, 1996) and it is there-
fore necessary to investigate the photochemistry of every
photosensitizing drug.
Phenothiazine derivatives have found a large variety of
applications as dyes, antioxidants, and drugs. Accordingly,
the antihistaminic and neuroleptic properties of some pheno-
thiazine derivatives are well-known (Asghar and Khan, 2008;
Elisei et al., 2002). Moreover, given the phototoxicity of these
drugs (Onoue and Tsuda,2006; Miolo et al., 2006) a large num-
ber of investigations on the photochemical properties of these
substances have been carried out. Several reports also indicate
that irradiation of phenothiazines can produce singlet oxygen
(Tranchin et al., 1998) but, surprisingly, very few studies have
dealt with the chemical reactivity of 1O2 with the phenothia-
zines themselves.
Scheme 1 Oxidative Photodegradation products of
trimeprazine.
Table 1 Effect of triplet energies of different sensitizers on the
yields of products.
Sensitizer Triplet energy
(kcal /mole)
Yields of product (%)
(2 + 4)
Methylene blue 33.5–34.0 60.9 (34.3 + 26.6)
Rose bengal 39.2–42.2 59.5 (32.3 + 27.2)
Riboﬂavin 57.8 50.4 (26.5 + 23.9)
Benzophenone 68.6–69.1 49.1 (25.1 + 24.0)
544 W. Ahmad et al.Trimeprazine (also known as Alimemazine) is a tricyclic
Phenothiazine derivative (Lutka and Koziara, 2000). It is
in the same class of drugs as chlorpromazine (Thorazine)
and triﬂuoperazine (Stelazine); however, unlike the other drugs
in this class, trimeprazine is not used clinically as an anti-psy-
chotic. It acts as anti-histamine, a sedative, and an anti-emetic
(anti-nausea) (Bello, 2011). Interest in the photo reactivity of
trimeprazine arises from the clinical and pharmacological re-
ports of phototoxic effects demonstrated by this drug (Mio
et al., 1999; Quintero and Miranda, 2000).
In pursuance of our interest in the photochemical reactions
involved in the phototoxicity of the photosensitizing drugs and
theirmechanisms, hereinwe have examined the photobehaviour
of the antihistaminic drug trimeprazine (a phenothiazine deriv-
ative) under aerobic condition. Photolysis of trimeprazine (1) in
the presence of oxygen resulted in the formation of two photo-
degradation products, identiﬁed as 2 and 4 from their spectral
(IR, 1H NMR, 13C NMR, mass spectra) properties (Scheme
1). The products are formed by oxidative photodegradation of
trimeprazine in an irreversible trappingof the self-photogenerat-
ed 1O2 in the type II photodynamic action of the drug.
2. Experimental
2.1. Apparatus and chemicals
All chemicals used were of analytical grade. Pure Trimeprazine
was obtained from Sigma Aldrich (India), IR spectra were re-
corded as KBr discs on a Perkin Elmer model spectrum RXI.
1H NMR and 13C NMR Spectra were recorded on a Bruker
Avance-DRX-300 Spectrometer using TMS as internal stan-
dard and CD3OD as solvent. High resolution mass spectra were
determined with a VG-ZAB-BEQ9 spectrometer at 70 eV ioni-
zation voltage. Merck silica gel 60 F254 plates were used for
analytical TLC; column chromatography was performed on
Merck silica gel 60 (60–120 mesh).
2.2. Photoirradiation procedure
A solution of Trimeprazine (275 mg, 0.7 mM) in methanol
(400 ml) under aerobic condition was irradiated for 1 h in a
Rayonet photochemical reactor (The Southern New England
Ultraviolet Co; Model RPR-208 equipped with four RUL-
350 nm ﬂuorescence lamps) for the complete conversion of
reactant. Progress of the reaction was monitored by thin layer
chromatography (chloroform–methanol, 98:2). At the end of
the reaction formation of two major photoproducts were indi-
cated on TLC and photoproducts were isolated by eluting with
dichloromethane–ethyl ether (1:1, v/v) on a silica column. Thephotoproducts were identiﬁed as, N,N2-trimethyl-3-(10H-
phenothiazin-10-yl sulfoxide) propan-1-amine (2) and N,2-di-
methyl-3-(10H-phenothiazin-10-yl) propan-1-amine ( 4) from
the following spectral properties:
2.3. N,N2-trimethyl-3-(10H-phenothiazin-10-yl sulfoxide)
propan-1-amine (2)
Yield: 95 mg (34.5%); HRMS calcd. for (M+) C18H22N2OS
314.1453. Found 314.1448; IR (KBr, cm1): 3416, 2965, 1388,
1301, 1270, 1209, 1055 (SO), 978, 763. 1H NMR (CD3OD,
300 MHz): d 7.12–6.9 (m, 8 H, arom), 4.60 (d, J= 7.3 Hz, 2
H, H-15), 2.32 (s, 6 H, H-19, H-20), 2.27 (d, J= 7.4 Hz, 2 H,
H-17), 2.13 (m, 1 H, H-16), 1.02 (d, J= 6.0 Hz, 3 H, H-21)
ppm. 13C NMR (CD3OD, 300 MHz): 145.1, 131.0, 128.6,
119.3, 118.2, 62.2, 55.3, 36.1, 32.1 16.0 ppm. MS: m/z: 314
(M+), 298 (M+16), 214 (M+100).
2.4. N,2-dimethyl-3-(10H-phenothiazin-10-yl) propan-1-amine
(4)
Yield: 75 mg (27.2%); HRMS calcd. for (M+) C17H20N2S
284.4191. Found 284.4185; IR (KBr, cm1): 1388, 1301, 1270,
1209, 978, 763. 1H NMR (CD3OD, 300 MHz): d 7.12–6.9 (m,
8H, arom), 4.50 (d, J= 7.3 Hz, 2 H, H-15), 2.38 (s, 3 H, H-
19), 2.26 (d, J= 7.4 Hz, 2 H, H-17), 2.14 (m, 1 H, H-16), 1.02
(d, J= 6.0 Hz, 3 H, H-20) ppm. 13C NMR (CD3OD,
300 MHz): d 145.2, 131.1, 128.7, 119.4, 118.3, 62.3, 55.4, 36.2,
32.2, 15.9 ppm. MS: m/z: 284 (M+), 198 (M+86).
2.5. Singlet oxygen detection
In order to conﬁrm the role of singlet oxygen 1O2 as a trigger
of trimeprazine (TMPZ) photodecomposition, photolysis was
performed under the same experimental condition but now
in the presence of 2,5-dimethylfuran (2,5-DMF) which is nor-
mally used as a trap for singlet oxygen (1O2) (Gollnick and
Griesbeck, 1983).
Similar experiment was also carried out by using different
sensitizers such as methylene blue, rose bengal, riboﬂavin,
and benzophenone to study the effect of triplet energy of sen-
sitizer on the percentage yields of products (Table 1).3. Results and discussion
The two major photoproducts, N,N2-trimethyl-3-(10H-pheno-
thiazin-10-yl sulfoxide) propan-1-amine (2) and N,2-dimethyl-
3-(10H-phenothiazin-10-yl) propan-1-amine (4), which were
Scheme 2 Mechanistic pathway of oxidative photodegradation of trimeprazine.
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oxygen atmosphere, are depicted in Scheme 1.
Their formation has been rationalized in the photosensitized
generation of singlet oxygen by the type II photodynamic action
of the drug and subsequent quenching of the generated singlet
oxygen by the drug as proposed in Scheme 2. Photoproduct 2
is formed by simple sulfoxidation of parent compound and pho-
toproduct 4 is formed through a mechanism in which a charge
transfer complex is formed involving the N-dimethyl amino
nitrogen of trimeprazine and 1O2. This complex, in addition to
intersystem crossing process, undergoes a-hydrogen abstraction
to form a transient a-amino carbon radical (3) and peroxy
radical (HO2). Both of these radicals can then undergo electron
transfer to produce an iminium cation leading to the N-
demethylation product 4. This mechanism is in agreement with
the photodegradation pathway proposed for N-demethylation
of trialkylamines (Baciocchi et al.,2004, 2006a,b). When trimep-
razine was irradiated with singlet oxygen scavenger 2,5-
dimethylfuran (2,5 DMF) it competes with the drug for singlet
oxygen (1O2), and decreased availability of singlet oxygen
(1O2) therefore slowed down the rate of photodegradation.
In order to further ascertain the oxidative photodegrada-
tion of trimeprazine by its quenching of the self-generated sin-
glet oxygen, the drug was photolysed under the same
experimental condition, in the presence of a well known photo-
sensitized singlet oxygen generator, where same photoproductswere obtained in different yields. Rose bengal and methylene
blue were much more efﬁcient than riboﬂavin and benzophe-
none in the photosensitized decomposition of 1 (Table 1). This
may be due to the fact that rose bengal and methylene blue,
with lower triplet energies, produce singlet oxygen in large
amounts (Tuite and Kelly, 1993; Roul and Cadet, 1996) by
type II mechanism (Foote, 1991). On the other hand riboﬂavin
and benzophenone (higher triplet energies) act mainly by type
I photosensitized photooxidation, do not produce signiﬁcant
amount of 1O2 (Wondrak et al., 2006).
The result indicates that these photoproducts are formed by
irreversible trapping of self-photogenerated singlet molecular
oxygen. The formation of photoproduct through oxygenation
is relevant to understand the mechanism of photobiological
effect of trimeprazine.
Usually, the self-sensitized drug photooxidation (or singlet
oxygen physical quenching) is barely considered, although
it would be important because if 1O2 is quenched, it will
not be available to react with other biologically relevant
substrates.
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